By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Galapagos NV 

Industriepark Mechelen Noord I, Zone L
Generaal De Wittelaan 11 A
Mechelen    B-2800  Belgium
Phone: 32-15-34-29-00 Fax: 32-15-34-29-01



Company News
Galapagos (GLPG.BR) Doses First Healthy Volunteer With CF Combo GLPG2222 And GLPG2451 2/24/2017 7:30:32 AM
Galapagos (GLPG.BR) Reports Strong Financial Results And Newsflow-Rich Pipeline 2/24/2017 7:27:20 AM
Galapagos (GLPG.BR) Doses First Patient With Novel CF Corrector GLPG2222 2/2/2017 7:47:16 AM
Galapagos (GLPG.BR) Release: Dr. Walid Abi-Saab Joins Company As Chief Medical Officer 1/18/2017 12:41:14 PM
Galapagos (GLPG.BR)'s SAPHIRA 1 Topline Shows Competitive Clinical Results In G551D Patients 12/21/2016 9:44:21 AM
Galapagos (GLPG.BR) Release: The Lancet Publishes FITZROY Study Results With Filgotinib In Crohn's 12/15/2016 10:21:25 AM
Galapagos (GLPG.BR) Release: Start Phase 2b/3 Study With Filgotinib In Ulcerative Colitis 12/9/2016 9:46:28 AM
Galapagos (GLPG.BR) Increases Share Capital Through Warrant Exercises 11/30/2016 9:42:39 AM
Galapagos (GLPG.BR) Initiates Phase 1 Study With Cystic Fibrosis Drug GLPG2737 11/29/2016 10:02:42 AM
Galapagos (GLPG.BR) Release: Phase 3 Study With Filgotinib Initiated In Crohn's Disease 11/23/2016 1:49:44 PM